Vaishali Pharma Limited
VAISHALI.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$848.96M
Close$
Share Statistics
| Market cap | $848.96 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.32 |
| Beta | 0.37 |
| Outstanding Shares | 130,462,130 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 23.23 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Vaishali Pharma Limited
27 employees
CEO: Hemanth Damodar Pathak Vaishali Pharma Limited functions as a pharmaceutical enterprise, conducting its business both within India and across global markets. The company's extensive product portfolio encompasses Active Pharmaceutical Ingredients (APIs), coveri...